The Food and Drug Administration has approved two new COVID vaccines, from Pfizer and Moderna, for the 2024–2025 cold and flu season. The vaccine is recommended for everyone in the U.S. six ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two COVID-19 vaccines.

They are monovalent vaccines — containing a single strain — that target the XBB.1.5 version of Omicron, which was the dominant subvariant when the vaccine strain was selected by the FDA in June.

Democrats on the U.S. Senate's health committee launched an investigation on Tuesday into Health Secretary Robert F. Kennedy ...

The US Food and Drug Administration on Monday gave the green light to updated Covid-19 vaccine booster shots from Moderna and Pfizer/BioNTech. The updated vaccines are each approved for people 12 ...

Topline The Food and Drug Administration gave its approval for emergency use Monday to new updated Covid-19 vaccines from Pfizer-BioNTech and Moderna that are specially designed to protect against ...

WASHINGTON — Food and Drug Administration Commissioner Marty Makary said the agency is planning to unveil new guidance for vaccine makers, focused primarily on Covid-19 shots, in the coming weeks.

FDA approves updated COVID vaccines to rev up protection this fall Single-dose vials of Pfizer’s updated COVID vaccine for adults, which was approved by U.S. regulators on Monday.

The new vaccines will target BA.4 and BA.5, plus the initial COVID-19 strain. The Food and Drug Administration on Thursday said it had advised COVID-19 vaccine companies to produce an updated ...

Novavax is also making a Covid vaccine for the fall, but the FDA hasn’t yet approved it. The vaccine targets a different strain of the virus, JN.1.